 "Sequent Scientific names Rajaram Narayanan as MD, CEO for five years")
Sequent Scientific, an animal health firm, on Friday said it has appointed Rajaram Narayanan as MD and CEO for five years, with effect from April 11, 2022.
Narayanan replaces Manish Gupta who has put in his papers.
The company's board, pursuant to the recommendation by the nomination and remuneration committee, approved the appointment of Narayanan as the MD and CEO for five years with effect from April 11, 2022, subject to the approval of the shareholders, Sequent Scientific said in a regulatory filing.
Narayanan, who has served in senior leadership roles across the pharmaceutical, consumer goods and services industries, succeeds Gupta who will step down effective April 10, 2022, after serving as the company's MD and CEO for the past eight years, it added.
Narayanan served as Sanofi India MD prior to joining Sequent.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app